Stories
Slash Boxes
Comments

SoylentNews is people

posted by cmn32480 on Wednesday November 25 2015, @03:24PM   Printer-friendly
from the precursor-to-skelegrow dept.

University of Southampton scientists are developing a new type of drug that may help bones heal faster by activating a stem cell regeneration gene:

Using bone samples from people undergoing hip replacement surgery, the researchers were able to show that the drug – a protein that activates a molecular pathway called the 'Wnt' pathway – causes stem cells found within bones to divide and to turn into more bone cells.

Dr Nick Evans, Associate Professor in Bioengineering at the University of Southampton and lead author of the study, says: "Bone fractures are a big problem in society, especially in older people. It is getting worse as more people get older and their risk of fracture increases. Most fractures heal completely by themselves, but a surprising number, around 10 per cent, take over six months to heal, or never heal at all. In the worst cases this can lead to several surgical operations, or even amputation.

"Through our research, we are trying to find ways to chemically stimulate Wnt signaling using drugs. To achieve this, we selectively deliver proteins and other molecules that change Wnt signalling specifically to stem cells, particularly in the bone. This may help us find cures for many diseases, including bone disease, and speed up bone healing after fracture."

However the researchers found that if the Wnt pathway was switched on too long, the regenerative effect was lost or, even reversed. "This is why it is particularly important to develop technologies for timed and targeted delivery, which is what we have done in this research," Nick added. The research is published in the journal Stem Cells.

More about the Wnt signaling pathway and PubMed search for WNT3A.

Transient Canonical Wnt Stimulation Enriches Human Bone Marrow Mononuclear Cell Isolates for Osteoprogenitors [abstract]

[...] Wnt stimulation resulted in an increase in the frequency of skeletal stem cells marked by the STRO-1bright/Glycophorin A phenotype. Osteogenesis was elevated in stromal cell populations arising from BMMNCs transiently stimulated by Wnt3A protein, but sustained stimulation inhibited osteogenesis in a concentration-dependent manner. These results demonstrate that Wnt stimulation could be used as a therapeutic approach by transient targeting of stem cell populations during early fracture healing, but that inappropriate stimulation may prevent osteogenesis.


Original Submission

This discussion has been archived. No new comments can be posted.
Display Options Threshold/Breakthrough Mark All as Read Mark All as Unread
The Fine Print: The following comments are owned by whoever posted them. We are not responsible for them in any way.
  • (Score: 2, Interesting) by Anonymous Coward on Wednesday November 25 2015, @07:10PM

    by Anonymous Coward on Wednesday November 25 2015, @07:10PM (#268099)

    Stem cells are particularly sensitive to their environment so the culturing conditions used heavily impact results. The group co-cultured the stem cells with stromal cells to better represent the physiological environment.

    Targeting a protein to a specific cell type is not an easy problem to solve and the Wnt signaling pathway is important for many different tissues so I don't foresee this becoming a treatment anytime soon. The delivery problem may be able to be subverted during surgery so it would be interesting to try it in that context.